Palatin Technologies
PTN
#10249
Rank
โ‚น2.53 B
Marketcap
โ‚น1,423
Share price
3.09%
Change (1 day)
18,462.55%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚น0.4 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚น8.84 Million. In 2024 the company made an earning of -โ‚น2.58 Billion, an increase over its 2023 earnings that were of -โ‚น3.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น0.4 Billion-84.66%
2024 -โ‚น2.58 Billion-16.9%
2023 -โ‚น3.11 Billion5.99%
2022 -โ‚น2.93 Billion-13.7%
2021 -โ‚น3.4 Billion33.25%
2020 -โ‚น2.55 Billion-172.11%
2019 โ‚น3.52 B2352.33%
2018 โ‚น0.14 B-94.13%
2017 โ‚น2.45 B-154.92%
2016 -โ‚น4.47 Billion3.67%
2015 -โ‚น4.31 Billion878%
2014 -โ‚น0.45 Billion-72.64%
2013 -โ‚น1.61 Billion-33.11%
2012 -โ‚น2.41 Billion77.71%
2011 -โ‚น1.36 Billion
2003 -โ‚น2.3 Billion29.93%
2002 -โ‚น1.77 Billion36.18%
2001 -โ‚น1.3 Billion
1999 -โ‚น1.08 Billion6.04%
1998 -โ‚น1.02 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.485 T-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.403 T-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น76.42 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น1.15 Billion 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น15.66 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.26 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น9.16 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.83 Billion 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.55 Billion 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA